Group One Trading’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-414,114
| Closed | -$24.3M | – | 8283 |
|
|
2023
Q4 | $24.3M | Buy |
414,114
+375,408
| +970% | +$21.1M | 0.06% | 274 |
|
|
2023
Q3 | $1.69M | Buy |
38,706
+2,658
| +7% | +$94.9K | 0.01% | 1789 |
|
|
2023
Q2 | $1.3M | Buy |
36,048
+18,938
| +111% | +$780K | ﹤0.01% | 2105 |
|
|
2023
Q1 | $636K | Sell |
17,110
-22,760
| -57% | -$1.02M | ﹤0.01% | 2537 |
|
|
2022
Q4 | $1.81M | Sell |
39,870
-31,713
| -44% | -$2.05M | ﹤0.01% | 1915 |
|
|
2022
Q3 | $5M | Sell |
71,583
-3,496
| -5% | -$259K | 0.01% | 1166 |
|
|
2022
Q2 | $5.04M | Buy |
75,079
+38,576
| +106% | +$2.45M | 0.01% | 1286 |
|
|
2022
Q1 | $3M | Buy |
36,503
+32,514
| +815% | +$3.33M | ﹤0.01% | 1989 |
|
|
2021
Q4 | $585K | Buy |
+3,989
| New | +$619K | ﹤0.01% | 3944 |
|
|
2019
Q2 | – | Sell |
-13,652
| Closed | -$1.06M | – | 5513 |
|
|
2019
Q1 | $1M | Buy |
13,652
+9,556
| +233% | +$650K | 0.01% | 1410 |
|
|
2018
Q4 | $174K | Buy |
4,096
+2,066
| +102% | +$82.3K | ﹤0.01% | 2796 |
|
|
2018
Q3 | $96K | Buy |
+2,030
| New | +$113K | ﹤0.01% | 3567 |
|
|
2018
Q2 | – | Sell |
-4,569
| Closed | -$173K | – | 5577 |
|
|
2018
Q1 | $140K | Buy |
+4,569
| New | +$127K | ﹤0.01% | 3028 |
|
|
2017
Q4 | – | Sell |
-4,759
| Closed | -$73.8K | – | 5334 |
|
|
2017
Q3 | $56K | Buy |
4,759
+1,659
| +54% | +$9.6K | ﹤0.01% | 3577 |
|
|
2017
Q2 | $11K | Hold |
3,100
| – | – | ﹤0.01% | 4191 |
|
|
2017
Q1 | $16K | Buy |
+3,100
| New | +$17K | ﹤0.01% | 3968 |
|
|
2015
Q3 | – | Sell |
-4,259
| Closed | -$129K | – | 5288 |
|
|
2015
Q2 | $134K | Buy |
+4,259
| New | +$126K | ﹤0.01% | 2861 |
|
Other funds holding MRTX
Group One Trading's MRTX Position: Q1 2024 in Review
Group One Trading sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 414,114 shares — an estimated $24.3M sold.
Group One Trading first reported a position in MRTX in Q2 2015 and held it in 17 quarters. The position peaked at $24.3M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Group One Trading reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Group One Trading sold 414,114 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $24.3M.
- Group One Trading first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2015 and held it in 17 quarters.
- Group One Trading's Mirati Therapeutics, Inc. Common Stock position peaked at $24.3M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.